1 Product identity
Ingredient risk
No flagged ingredients

5-HTP Extended Release 200 mg

BrandSeeking HealthAmino acid/Protein Tablet or Pill 7 ingredients DSLD #210756
Net contents: 30 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2020-01-25
2 Ingredients (7)
IngredientGroupSafety
5-HTP5-HTPLimited Evidence
Dicalcium PhosphateCalciumConditionally Safe
HPMCHypromellose
Ascorbyl PalmitateVitamin CGenerally Safe
Microcrystalline CelluloseCellulose
Guar GumGuar
SilicaSiliconGenerally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
5-HTP — Limited Evidence
⚠ SEROTONIN SYNDROME with SSRIs — SERIOUS
⚠ GI disturbance
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
5 Data source
DSLD ID210756
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2020-01-25
6 More from Seeking Health
View Seeking Health Safety Scorecard → 53 products
5-HTP 50 mgBenfotiamineBone NutrientsCaprylic Acid 250 mgCopper 2 mgD-Ribose
7 Cite this page
Vancouver
Pkhakadze G. 5-HTP Extended Release 200 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 14]. Available from: https://supplement.ge/products/5-htp-extended-release-200-mg-210756/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG